ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

The Fine-Tuning of CXCL8 Protects Kidney Against Ischemia-Reperfusion Injury in Mice Lacking MicroRNA-146a.

L. Amrouche,1,2 G. Desbuissons,1 M. Rabant,1,2 C. Legendre,1,2 F. Terzi,2 D. Anglicheau.1,2

1U1151, INSERM, Paris, France, Metropolitan
2Department of Kidney Transplantation, Necker hospital, Paris, France, Metropolitan.

Meeting: 2016 American Transplant Congress

Abstract number: C94

Keywords: Kidney transplantation, knockout, Mice, Nuclear factor-kappa B (NF-kB), Renal ischemia

Session Information

Date: Monday, June 13, 2016

Session Name: Poster Session C: Ischemia Reperfusion Injury and Organ Preservation

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Ischemia-Reperfusion Injury Following Transplantation: Implications for the Modulation of CXCL8 Chemokine Function.
  • Preoperative Fasting Protects Aged Obese Mice Against Renal Ischemia-Reperfusion Injury

Acute kidney injury leads to the development of tubular injury and interstitial inflammation that need to be controlled to avoid fibrosis development. We hypothesized that microRNAs (miRNAs) are involved in the regulation of the balance between lesions and adaptive repair.

Using HK2 human proximal tubular cells, we studied in vitro the response to pro-inflammatory cytokines and the regulation of miR-146a. We explored its targets in HK2 cells after stimulation by IL-1β. In vivo we explored the effect of unilateral renal ischemia-reperfusion injury (IRI) in WT or miR-146a invalidated mice.

In pro-inflammatory conditions, we identified miR-146a to be transcriptionally upregulated by ligands of the interleukin-1-toll-like receptor signaling in HK2 cells. IL-1β induced miR-146a expression in a time- and concentration-dependent manner through the activation of NF-κB, as confirmed by siRNA and luciferase reporter experiments. MiR-146a acted as a negative feedback regulator of this pathway by targeting IRAK1, thus decreasing CXCL8/CXCL1 expression by injured tubular cells. In vivo, miR-146a was found to be induced in response to IRI in a mouse model of renal unilateral IRI 7 days after the injury. In human, miR-146a was found to be induced in the renal allograft of patients who experienced acute tubular necrosis early after transplantation as compared to patients with normal allograft biopsy results (P<.05). in the renal allograft and the urine of kidney transplant recipients, and in a mouse model of renal unilateral IRI seven days after the injury. Mir-146a levels were also increased in urine samples collected ten days after renal transplantation in recipients of a deceased donor kidney as compared to recipients of a living donor kidney (P<0.01). In situ hybridization localized up-regulated miR-146a mostly in tubular cells after IRI. Fourteen days after unilateral IRI, miR-146a-/- mice had greater tubular injury, inflammatory infiltrate and fibrosis compared with wild-type mice. Inhibition of the CXCL8/CXCL1 signaling using reparixin, a CXCR2 inhibitor, prevented the development of tubular injury, inflammation and fibrosis after IRI in miR-146a-/- mice.

In conclusion, these results highlight miR-146a as a key mediator of the renal response to injury by limiting the consequences of inflammation, a key process in the development of acute and chronic kidney diseases.

CITATION INFORMATION: Amrouche L, Desbuissons G, Rabant M, Legendre C, Terzi F, Anglicheau D. The Fine-Tuning of CXCL8 Protects Kidney Against Ischemia-Reperfusion Injury in Mice Lacking MicroRNA-146a. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Amrouche L, Desbuissons G, Rabant M, Legendre C, Terzi F, Anglicheau D. The Fine-Tuning of CXCL8 Protects Kidney Against Ischemia-Reperfusion Injury in Mice Lacking MicroRNA-146a. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/the-fine-tuning-of-cxcl8-protects-kidney-against-ischemia-reperfusion-injury-in-mice-lacking-microrna-146a/. Accessed January 22, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
    • Penis Transplantation: First U.S. Experience.
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
    • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.